• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芳基霉素D类抗生素的初步分析

Initial Analysis of the Arylomycin D Antibiotics.

作者信息

Tan Yun Xuan, Peters David S, Walsh Shawn I, Holcomb Matthew, Santos-Martins Diogo, Forli Stefano, Romesberg Floyd E

机构信息

Department of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.

Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, California 92037, United States.

出版信息

J Nat Prod. 2020 Jul 24;83(7):2112-2121. doi: 10.1021/acs.jnatprod.9b01174. Epub 2020 Jul 2.

DOI:10.1021/acs.jnatprod.9b01174
PMID:32614583
Abstract

The arylomycins are a class of natural product antibiotics that inhibit bacterial type I signal peptidase and are under development as therapeutics. Four classes of arylomycins are known, arylomycins A-D. Previously, we reported the synthesis and analysis of representatives of the A, B, and C classes and showed that their spectrum of activity has the potential to be much broader than originally assumed. Along with a comparison of the mechanism of acquired and innate resistance, this led us to suggest that the arylomycins are latent antibiotics, antibiotics that once possessed broad-spectrum activity, but which upon examination today, have only narrow spectrum activity due to prior selection for resistance in the course of the competition with other microorganisms that drove their evolution in the first place. Interestingly, actinocarbasin, the only identified member of the arylomycin D class, has been reported to have activity against MRSA. To confirm and understand this activity, several actinocarbasin derivatives were synthesized. We demonstrate that the previously reported structure of actinocarbasin is incorrect, identify what is likely the correct scaffold, confirm that scaffold has activity against MRSA, and determine the origin of this activity.

摘要

芳基霉素是一类天然产物抗生素,可抑制细菌I型信号肽酶,目前正作为治疗药物进行研发。已知有四类芳基霉素,即芳基霉素A - D。此前,我们报道了A、B和C类芳基霉素代表物的合成与分析,并表明它们的活性谱可能比最初设想的要广泛得多。通过比较获得性耐药和固有耐药的机制,这使我们提出芳基霉素是潜在抗生素,即曾经具有广谱活性,但如今经检测,由于在与最初推动其进化的其他微生物竞争过程中预先选择了耐药性,所以仅具有窄谱活性。有趣的是,据报道,芳基霉素D类中唯一已鉴定的成员放线碳霉素对耐甲氧西林金黄色葡萄球菌(MRSA)具有活性。为了证实并了解这种活性,合成了几种放线碳霉素衍生物。我们证明了先前报道的放线碳霉素结构是错误的,确定了可能正确的骨架,证实该骨架对MRSA具有活性,并确定了这种活性的来源。

相似文献

1
Initial Analysis of the Arylomycin D Antibiotics.芳基霉素D类抗生素的初步分析
J Nat Prod. 2020 Jul 24;83(7):2112-2121. doi: 10.1021/acs.jnatprod.9b01174. Epub 2020 Jul 2.
2
Efforts toward broadening the spectrum of arylomycin antibiotic activity.拓宽阿霉素抗生素活性谱的努力。
Bioorg Med Chem Lett. 2013 Oct 15;23(20):5654-9. doi: 10.1016/j.bmcl.2013.08.026. Epub 2013 Aug 14.
3
Broad-spectrum antibiotic activity of the arylomycin natural products is masked by natural target mutations.芳基霉素天然产物的广谱抗生素活性被天然靶点突变所掩盖。
Chem Biol. 2010 Nov 24;17(11):1223-31. doi: 10.1016/j.chembiol.2010.09.009.
4
Initial efforts toward the optimization of arylomycins for antibiotic activity.优化芳基霉素类抗生素活性的初步努力。
J Med Chem. 2011 Jul 28;54(14):4954-63. doi: 10.1021/jm1016126. Epub 2011 Jun 28.
5
Synthesis and biological characterization of arylomycin B antibiotics.芳霉素 B 抗生素的合成与生物学特性研究。
J Nat Prod. 2011 May 27;74(5):956-61. doi: 10.1021/np200163g. Epub 2011 May 5.
6
A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.一种假定的cro样阻遏物导致金黄色葡萄球菌对芳基霉素产生抗性。
Antimicrob Agents Chemother. 2015;59(6):3066-74. doi: 10.1128/AAC.04597-14. Epub 2015 Mar 9.
7
Mechanism of action of the arylomycin antibiotics and effects of signal peptidase I inhibition.芳基霉素抗生素的作用机制及信号肽酶 I 抑制的影响。
Antimicrob Agents Chemother. 2012 Oct;56(10):5054-60. doi: 10.1128/AAC.00785-12. Epub 2012 Jul 16.
8
Inhibition of Protein Secretion in and Sub-MIC Effects of Arylomycin Antibiotics.抑制蛋白分泌及芳香霉素抗生素的亚抑菌效应。
Antimicrob Agents Chemother. 2019 Jan 29;63(2). doi: 10.1128/AAC.01253-18. Print 2019 Feb.
9
Origins of Yersinia pestis sensitivity to the arylomycin antibiotics and the inhibition of type I signal peptidase.鼠疫耶尔森菌对芳基霉素类抗生素敏感性及I型信号肽酶抑制作用的起源
Antimicrob Agents Chemother. 2015 Jul;59(7):3887-98. doi: 10.1128/AAC.00181-15. Epub 2015 Apr 20.
10
Optimized arylomycins are a new class of Gram-negative antibiotics.优化的芳基霉素是一类新型的革兰氏阴性抗生素。
Nature. 2018 Sep;561(7722):189-194. doi: 10.1038/s41586-018-0483-6. Epub 2018 Sep 12.

引用本文的文献

1
Cyclization by Intramolecular Suzuki-Miyaura Cross-Coupling-A Review.分子内铃木-宫浦交叉偶联环化反应综述
Chemistry. 2025 Jan 2;31(1):e202402664. doi: 10.1002/chem.202402664. Epub 2024 Nov 14.
2
A Review of Antibacterial Candidates with New Modes of Action.具有新型作用机制的抗菌候选药物综述。
ACS Infect Dis. 2024 Oct 11;10(10):3440-3474. doi: 10.1021/acsinfecdis.4c00218. Epub 2024 Jul 17.
3
Antibiotics in the clinical pipeline as of December 2022.截至 2022 年 12 月处于临床研发管线中的抗生素。
J Antibiot (Tokyo). 2023 Aug;76(8):431-473. doi: 10.1038/s41429-023-00629-8. Epub 2023 Jun 8.
4
Bacterial Signal Peptides- Navigating the Journey of Proteins.细菌信号肽——蛋白质之旅的导航
Front Physiol. 2022 Jul 26;13:933153. doi: 10.3389/fphys.2022.933153. eCollection 2022.
5
Emerging peptide antibiotics with therapeutic potential.具有治疗潜力的新型肽类抗生素。
Med Drug Discov. 2021 Mar;9:100078. doi: 10.1016/j.medidd.2020.100078. Epub 2020 Dec 30.